GSK Investigational Site

Sfax 3029

0 studies enrolling now · 6 studies all time

What they study most

Neoplasms, Breast, Neoplasms, Prostate, Purpura, Thrombocytopaenic, Idiopathic

Studies at this site

• Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer — Completed
• RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag — Completed
• LENS - Long-term Eltrombopag Observational Study — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer — Completed
• Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer — Completed